25I-NB3OMe: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
{{Short description|A synthetic psychedelic drug}}
{{DISPLAYTITLE:25I-NB3OMe}}
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477002123
| IUPAC_name = 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
| image = 25I-NB3OMe.svg
| width = 200px
}}


'''25I-NB3OMe''' is a synthetic psychedelic compound belonging to the [[phenethylamine]] class. It is a derivative of the more well-known psychedelic [[2C-I]] and is part of the [[NBOMe]] series of compounds, which are known for their potent effects at low doses.
== 25I-NB3OMe ==
[[File:25I-NB3OMe.svg|thumb|right|Chemical structure of 25I-NB3OMe]]
25I-NB3OMe, also known as 2C-I-NBOMe, is a synthetic psychedelic compound that belongs to the [[NBOMe]] class. It is a derivative of the phenethylamine 2C-I and is known for its potent hallucinogenic effects.  


==Chemical structure and properties==
== Chemical Structure and Properties ==
25I-NB3OMe is chemically related to [[2C-I]], with the addition of a 2-methoxybenzyl group to the nitrogen atom of the ethylamine chain. This modification significantly increases the compound's potency compared to its parent compound. The presence of the iodine atom at the 4-position of the phenyl ring is a characteristic feature of this class of compounds.
25I-NB3OMe is chemically related to the 2C family of phenethylamines, specifically 2C-I. The compound is characterized by the presence of a methoxy group at the 3-position of the benzene ring, which is a modification from the parent compound 2C-I. This modification significantly increases the compound's affinity for the [[serotonin receptor|5-HT2A receptor]], which is believed to be responsible for its psychedelic effects.


==Pharmacology==
== Pharmacology ==
25I-NB3OMe acts primarily as a potent agonist of the [[5-HT2A receptor]], which is the primary target for most classical psychedelics. Activation of this receptor is responsible for the hallucinogenic effects experienced by users. The compound's high affinity for the 5-HT2A receptor makes it active at very low doses, which can increase the risk of overdose.
The primary mechanism of action for 25I-NB3OMe is its agonistic activity at the 5-HT2A receptor, a subtype of the [[serotonin receptor]] that is commonly associated with the effects of classic psychedelics such as [[LSD]] and [[psilocybin]]. The compound's high potency and efficacy at this receptor make it a powerful hallucinogen, even at low doses.


==Effects==
== Effects ==
The effects of 25I-NB3OMe are similar to those of other psychedelics, including altered perception of time and space, visual hallucinations, and changes in thought processes. However, due to its high potency, the effects can be more intense and unpredictable. Users may experience both positive effects, such as euphoria and enhanced creativity, and negative effects, such as anxiety and paranoia.
Users of 25I-NB3OMe report a range of effects, including visual and auditory hallucinations, altered perception of time, and changes in mood and thought patterns. The intensity and duration of these effects can vary significantly depending on the dose and individual sensitivity.


==Risks and safety==
== Risks and Safety ==
The use of 25I-NB3OMe carries significant risks, particularly due to its potency and the potential for overdose. Adverse effects can include [[tachycardia]], [[hypertension]], [[seizures]], and in severe cases, death. The compound's safety profile is not well-established, and it is often sold as a "research chemical" with little information on safe dosing.
25I-NB3OMe is associated with several risks, particularly due to its high potency. Overdose can lead to severe adverse effects, including [[vasoconstriction]], [[hypertension]], and [[tachycardia]]. There have been reports of fatalities associated with the use of NBOMe compounds, often due to misidentification or improper dosing.


==Legal status==
== Legal Status ==
The legal status of 25I-NB3OMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Users should be aware of the legal implications of possessing or distributing this compound.
The legal status of 25I-NB3OMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Users should be aware of the legal implications of possessing or distributing this compound.


==Related pages==
== Related Compounds ==
* [[2C-I]]
* [[2C-I]]
* [[NBOMe series]]
* [[25I-NBOMe]]
* [[NBOMe]]
 
== Related Pages ==
* [[Psychedelic drug]]
* [[Psychedelic drug]]
* [[5-HT2A receptor]]
* [[Serotonin receptor]]
* [[Hallucinogen]]


[[Category:Psychedelic phenethylamines]]
[[Category:Psychedelic phenethylamines]]
[[Category:Designer drugs]]
[[Category:Serotonin receptor agonists]]
[[Category:Iodoarenes]]

Latest revision as of 03:29, 13 February 2025


25I-NB3OMe[edit]

File:25I-NB3OMe.svg
Chemical structure of 25I-NB3OMe

25I-NB3OMe, also known as 2C-I-NBOMe, is a synthetic psychedelic compound that belongs to the NBOMe class. It is a derivative of the phenethylamine 2C-I and is known for its potent hallucinogenic effects.

Chemical Structure and Properties[edit]

25I-NB3OMe is chemically related to the 2C family of phenethylamines, specifically 2C-I. The compound is characterized by the presence of a methoxy group at the 3-position of the benzene ring, which is a modification from the parent compound 2C-I. This modification significantly increases the compound's affinity for the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects.

Pharmacology[edit]

The primary mechanism of action for 25I-NB3OMe is its agonistic activity at the 5-HT2A receptor, a subtype of the serotonin receptor that is commonly associated with the effects of classic psychedelics such as LSD and psilocybin. The compound's high potency and efficacy at this receptor make it a powerful hallucinogen, even at low doses.

Effects[edit]

Users of 25I-NB3OMe report a range of effects, including visual and auditory hallucinations, altered perception of time, and changes in mood and thought patterns. The intensity and duration of these effects can vary significantly depending on the dose and individual sensitivity.

Risks and Safety[edit]

25I-NB3OMe is associated with several risks, particularly due to its high potency. Overdose can lead to severe adverse effects, including vasoconstriction, hypertension, and tachycardia. There have been reports of fatalities associated with the use of NBOMe compounds, often due to misidentification or improper dosing.

Legal Status[edit]

The legal status of 25I-NB3OMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Users should be aware of the legal implications of possessing or distributing this compound.

Related Compounds[edit]

Related Pages[edit]